Established 1999
 
8,000 companies from
USA,Canada and India.
 
   
Search over 25,000 News & Earnings Archives    
 
IPO Outlook: 
TechTarget IPO Rises at Start
Author: Yordanka Bahchevanska
123jump.com
Last Update: 3:46 PM EDT May 23 2007


(Continued)

Email article | Print article

As much as eleven new IPOs were launched during the past busy week for the IPO market. Insulet shares rose on their first day of trading Tuesday but traded flat at the end of the week. One of the week’s most anticipated IPOs, TechTarget, rose 14% from its offering price at the closing bell on Thursday. Ninety five IPOs have been priced so far in 2007 and 68% of them are trading above their offering price.

 
The selling stockholders have granted the underwriters a 30-day option to purchase up to 562,500 additional shares to cover over-allotments.

Pinnacle Gas Resources explores and develops domestic onshore natural gas reserves, primarily located in the Rocky Mountain region.

The shares ended the week at $8.54, down 6% from the offering price.

IPO CALENDAR – week of May 21st

B&G Foods (BGS: chart) plans to offer 13.9 million shares within a price range of $12 to $14 a share. Credit Suisse and Lehman Brothers will manage the deal.

Alternative energy provider Clean Energy Fuels (CLNE: chart) plans to offer 20 million shares, including 10 million from insiders, within a price range of $13 and $17 per share, in a bid to raise $391 million. WR Hambrecht will manage the Open Dutch auction style IPO.

The Cayman Islands-based reinsurer Greenlight Capital Re (GLRE: chart) plans to offer 10.3 million shares within a price range of $16 and $18 a share, in a bid to raise $212.2 million. Lehman Brothers and UBS will underwrite the deal.

Life sciences company Helicos BioSciences (HLCS: chart) plans to offer 5.4 million shares within a price range of $13 and $15 a share, in a bid to raise $68.3 million. UBS will be the underwriter on the deal.

Equipment leasing company RSC Holdings (RRR: chart) plans to offer 20.8 million shares, including 8.3 million from insiders, within a price range of $23 to $25 a share, in a bid to raise $452 million. Deustche Bank, Morgan Stanley and Lehman Brothers will be the managers on the deal.

Biopharmaceutical company Sirtris Pharmaceutical (SIRT: chart) plans to offer 5 million shares within a price range of $9 to $11 per share, in a bid to raise $60 million. J.P. Morgan and CIBC will underwrite the deal.

Israeli laboratory software provider STARLIMS (LIMS: chart) plans to sell 2.1 million shares within a price range of $13.5 to $15.5 a share, in a bid to raise $37.4 million. Oppenheimer and JMP Securities will manage the deal.
  1  2  3  4 More: IPO Outlook Archive

 


 

350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries

© 1999-2008 123jump.com. All rights reserved